| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/27/2005 | CN1610691A 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610560A Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 04/27/2005 | CN1610556A Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 04/27/2005 | CN1610552A Antipruritics |
| 04/27/2005 | CN1610550A Pharmaceutical formulations comprising an immune response modifier |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1609197A High-yield reverse immunization for finding tumor specific antigen and tumor specific antigen determinant |
| 04/27/2005 | CN1609196A High-yield T lymphocyte cloning technology for finding tumor specific antigen and tumor specific antigen determinant |
| 04/27/2005 | CN1609118A Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use |
| 04/27/2005 | CN1608671A Chinese medicine prepn for enhancing physique and raising immunity |
| 04/27/2005 | CN1198929C Antibodies against interferon alpha/beta receptor |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198647C Antibodies against human CD40 |
| 04/27/2005 | CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 04/27/2005 | CN1198642C Pharmaceutical application of mammal cell kinetin synthetic inhibitory factor |
| 04/27/2005 | CN1198639C Immune enhancing compositions |
| 04/27/2005 | CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884869 Pentapeptide compounds and uses related thereto |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884786 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884623 Using plant virions for vaccine preparation; gene therapy |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | US6884440 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors |
| 04/26/2005 | CA2209487C Imidazo[4,5-c]quinoline amines |
| 04/26/2005 | CA2152505C Method for preparing a viral aerosol |
| 04/21/2005 | WO2005035786A2 Methods for the risk estimation of bronchiectasis using ifngamma and cxcr1 gene polymorphisms |
| 04/21/2005 | WO2005035754A1 Double specific antibodies substituting for functional protein |
| 04/21/2005 | WO2005035586A1 Fused protein composition |
| 04/21/2005 | WO2005035583A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | WO2005035571A1 Novel glycoprotein and medicinal composition containing the same |
| 04/21/2005 | WO2005035546A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035532A1 Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005034983A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 04/21/2005 | WO2005034942A1 Animal feed composition |
| 04/21/2005 | WO2005034934A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | WO2005034916A1 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
| 04/21/2005 | WO2005020882A3 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 04/21/2005 | WO2005016969A3 Cd20-binding polypeptide compositions |
| 04/21/2005 | WO2005014525A3 Bi-aryl compound having immunosuppressive activity |
| 04/21/2005 | WO2004087181A3 ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING ω3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF |
| 04/21/2005 | WO2004080398A3 1-amino 1h-imidazoquinolines |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/21/2005 | US20050085505 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085456 Compounds useful in therapy |
| 04/21/2005 | US20050085448 Viricides against herpes virus; autoimmune disease; antitumor agents |
| 04/21/2005 | US20050085434 Ballast administering to human skins; dna vaccine; high density core overcoated with amorphous reservoir containing dna |
| 04/21/2005 | US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/21/2005 | US20050084527 Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2542593A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542042A1 Antibody composition specifically binding to il-5 receptor |
| 04/21/2005 | CA2541126A1 Animal feed composition |
| 04/21/2005 | CA2539449A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | CA2538099A1 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin |
| 04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523988A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523481A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1523315A1 3-o-[alfa-l-rhamnopyranosyl-(1-2)-alfa-l-rhamnopyranosyl-(1-4)-3beta-d-glucopyranosyl]-25(s)-spirostan-3beta-ol, process for its isolation, and its use as immunomodulator |